期刊文献+

武汉地区丙型肝炎病毒基因分型与慢性丙型肝炎患者肝功能和血液指标分析 被引量:9

Patients with hepatitis C for genotyping,liver function and blood analysis in Wuhan area
下载PDF
导出
摘要 目的了解武汉地区慢性丙型肝炎患者基因型分布特点,分析HCV不同基因型患者肝功能及血液学指标的变化。方法应用逆转录-聚合酶链反应(RT-PCR)技术对临床已诊断为丙肝患者(病例组)进行HCVRNA载量检测,并使用PCR直接测序法进行HCV基因分型,同时检测每位患者肝功能和血液学指标。另选90例健康体检者(对照组)进行相同检测。结果 90例慢性丙肝患者中以HCV1b型和2a型为主,分别为74例(82%,RNA载量对数值为8.19±2.33)和7例(7.2%,RNA载量对数值为6.12±1.56)。患者肝功能指标高于对照组,血液学指标低于对照组(P<0.05或P<0.01),但不同基因型患者肝功能和血液学指标测值未见明显差异(P>0.05)。结论武汉地区HCV基因分型及慢性丙肝患者肝功能、血液学检查对临床治疗有重要意义。 Objective To study the distribution characteristics of Wuhan area in patients of hepatitis C,analysis the change of liver function and blood indexes in different HCV genotype.Methods Quantitative detection of HCVRNA for the clinical diagnosis of hepatitis C patients(the case group),and using reverse transcription-polymerase chain reaction(RT-PCR).Direct sequencing for HCV genotyping and each patient were detected in liver function and blood analysis.Another 90 healthy subjects(control group) were the same detection.Results In 90 patients,there were HCV1b 74 cases(82%,HCV RNA 8.19±2.33)and 2a 7 cases(7.2%,HCV RNA 6.12±1.56).The liver function of case group was higher than control group and blood indexes were lower(P0.05).But the liver function and blood indexes of different HCV genotype had no significant difference(P0.05).Conclusion The genotype,liver function and blood indexes in patients of hepatitis C in Wuhan area has important clinical significance in clincal treatment.
出处 《国际检验医学杂志》 CAS 2013年第13期1693-1695,共3页 International Journal of Laboratory Medicine
基金 国家临床重点专科建设项目(财社[2010]305号)
关键词 肝炎 丙型 慢性 基因型 RNA 病毒 逆转录聚合酶链反应 hepatitis C chronic genotype RNA viral reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献10

二级参考文献57

共引文献820

同被引文献94

  • 1白兴文,谢建华,巩秀华,石灵敏,李荣,陈刚.同德县藏族人群乙型肝炎血清流行病学特征分析[J].青海医药杂志,2007,37(10):49-50. 被引量:4
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3樊和斌,郭亚兵,杨洁,侯金林,王战会,朱幼芙,秦劲峰.慢性乙型肝炎患者HBV基因型及其临床意义[J].第一军医大学学报,2005,25(2):229-230. 被引量:15
  • 4张占卿,张沝,陆伟,童海涛.血清生化指标对肝纤维化程度的预测价值[J].中国现代医学杂志,2007,17(3):291-293. 被引量:23
  • 5中华医学会肝病学分会 中华医学会传染病与寄生虫病学分会.丙型肝炎防治指南[J].中华医学杂志,2004,84:775-780.
  • 6Pazhanivel M,Jayanthi V.Diabetes mellitus and cirrhosis liver Minerva Gastroenterol Dietol[J].2010,56(1):7-11.
  • 7Bassendine MF,Sheridan DA,Bridge SH,et al.Lipids and HCV[J].Semin Immunopathol,2013,35 (1):87-100.
  • 8Koike K,Tsutsumi T,Yotsuyanagi H,et al.Lipid metabolism and live disease in hepatitis C viral infection[J].Oncology,2010,78 (suppl 1):24-30.
  • 9World Health Organization. Global policy report on the prevention and control of viral hepatitis-In WHO member states. 2013. http://www, who. int.
  • 10Nathan Ford, Catherine Kirby, Kasha Singh, et al. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bulletin of the World Health Organization, 2012, 90 :540-550.

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部